First Report of Evolut Pro+ Transcatheter Aortic Valve-in-Valve in a Degenerated Lotus Valve

IF 1.4 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Thorald Stolte BSc , David Winkel MD , Philip Haaf MD , Thomas Nestelberger MD
{"title":"First Report of Evolut Pro+ Transcatheter Aortic Valve-in-Valve in a Degenerated Lotus Valve","authors":"Thorald Stolte BSc ,&nbsp;David Winkel MD ,&nbsp;Philip Haaf MD ,&nbsp;Thomas Nestelberger MD","doi":"10.1016/j.shj.2023.100229","DOIUrl":null,"url":null,"abstract":"<div><p>The increasing use of transcatheter aortic valves in patients with aortic stenosis has led to a higher number of valve-in-valve procedures due to gradual valve degeneration. We present a case of a 72-year-old woman who received transcatheter aortic valve implantation (TAVI) using a Lotus valve due to severe aortic stenosis, which showed valve degeneration several years after the initial procedure. After heart-team discussion, TAVI-in-TAVI was planned using an Evolut pro+ valve, which allowed for full coverage of the Lotus valve and maintenance of coronary flow, resulting in a well-functioning valve with no regurgitation and normal performance. Despite high-risk anatomic features, valve-in-valve using an Evolut pro+ in a degenerated Lotus valve is feasible and overcomes pitfalls such as entanglement or coronary obstruction.</p></div>","PeriodicalId":36053,"journal":{"name":"Structural Heart","volume":"8 1","pages":"Article 100229"},"PeriodicalIF":1.4000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2474870623001239/pdfft?md5=93bb4aaaa4d692aae5398e3c03b53b46&pid=1-s2.0-S2474870623001239-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Structural Heart","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2474870623001239","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

The increasing use of transcatheter aortic valves in patients with aortic stenosis has led to a higher number of valve-in-valve procedures due to gradual valve degeneration. We present a case of a 72-year-old woman who received transcatheter aortic valve implantation (TAVI) using a Lotus valve due to severe aortic stenosis, which showed valve degeneration several years after the initial procedure. After heart-team discussion, TAVI-in-TAVI was planned using an Evolut pro+ valve, which allowed for full coverage of the Lotus valve and maintenance of coronary flow, resulting in a well-functioning valve with no regurgitation and normal performance. Despite high-risk anatomic features, valve-in-valve using an Evolut pro+ in a degenerated Lotus valve is feasible and overcomes pitfalls such as entanglement or coronary obstruction.

Evolut Pro+ 经导管主动脉瓣内置瓣膜用于退化的莲花瓣的首次报告
随着主动脉瓣狭窄患者越来越多地使用经导管主动脉瓣,因瓣膜逐渐退化而导致的瓣中瓣手术也越来越多。我们报告了一例 72 岁女性患者的病例,她因主动脉瓣严重狭窄而接受了使用 Lotus 瓣膜的经导管主动脉瓣植入术(TAVI),但在首次手术数年后出现了瓣膜退化。经心脏团队讨论后,计划使用 Evolut pro+ 瓣膜进行 TAVI 中 TAVI,该瓣膜可完全覆盖 Lotus 瓣膜并维持冠状动脉血流,术后瓣膜功能良好,无反流,性能正常。尽管存在高风险的解剖特征,但在退化的Lotus瓣膜上使用Evolut pro+瓣中瓣是可行的,并能克服缠绕或冠状动脉阻塞等隐患。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Structural Heart
Structural Heart Medicine-Cardiology and Cardiovascular Medicine
CiteScore
1.60
自引率
0.00%
发文量
81
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信